U.S. Markets close in 5 hrs 46 mins

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
227.96+1.26 (+0.56%)
As of 10:13AM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3306.08
52 Week Low 3197.47
50-Day Moving Average 3218.37
200-Day Moving Average 3261.94

Share Statistics

Avg Vol (3 month) 32.1M
Avg Vol (10 day) 32.19M
Shares Outstanding 5260.04M
Float 259.64M
% Held by Insiders 10.09%
% Held by Institutions 196.01%
Shares Short (Nov 12, 2020) 42.75M
Short Ratio (Nov 12, 2020) 40.91
Short % of Float (Nov 12, 2020) 41.06%
Short % of Shares Outstanding (Nov 12, 2020) 41.06%
Shares Short (prior month Oct 14, 2020) 43.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Aug 23, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 44.91%
Operating Margin (ttm)44.67%

Management Effectiveness

Return on Assets (ttm)17.78%
Return on Equity (ttm)40.20%

Income Statement

Revenue (ttm)5.99B
Revenue Per Share (ttm)23.07
Quarterly Revenue Growth (yoy)62.00%
Gross Profit (ttm)1.86B
Net Income Avi to Common (ttm)2.69B
Diluted EPS (ttm)10.20
Quarterly Earnings Growth (yoy)1,060.40%

Balance Sheet

Total Cash (mrq)6.15B
Total Cash Per Share (mrq)23.65
Total Debt (mrq)546.51M
Total Debt/Equity (mrq)6.72
Current Ratio (mrq)3.72
Book Value Per Share (mrq)31.26

Cash Flow Statement

Operating Cash Flow (ttm)3.21B
Levered Free Cash Flow (ttm)2.07B